The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$700K | 16 yrs ago

About AerovectRx

AerovectRx is an aerosol therapeutic company providing effective and dosage-controlled drug delivery using the respiratory system as the gateway for better health. Products under development by AerovectRx are designed to deliver a wide variety of therapies through multiple-use mass immunization as well as personal-use nebulizers. Potential targeted therapeutic candidates for the AerovectRx technology include treatments for asthma, cystic fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), diabetes, pain management, and for delivery of vaccines and anti-viral drugs.

AerovectRx Headquarter Location

303 Patleigh Road Suite 4150

Catonsville, Maryland, 21228,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AerovectRx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AerovectRx is included in 1 Expert Collection, including Diabetes.



1,750 items

  • When was AerovectRx founded?

    AerovectRx was founded in 2005.

  • Where is AerovectRx's headquarters?

    AerovectRx's headquarters is located at 303 Patleigh Road, Catonsville.

  • What is AerovectRx's latest funding round?

    AerovectRx's latest funding round is Series A.

  • How much did AerovectRx raise?

    AerovectRx raised a total of $700K.

  • Who are the investors of AerovectRx?

    Investors of AerovectRx include Advanced Technology Development Center, Emergent Growth Fund, Georgia Venture Partners, Atlanta Technology Angels, Seed Capital Fund of CNY and 3 more.

  • Who are AerovectRx's competitors?

    Competitors of AerovectRx include Valeritas, MediQuest Therapeutics, Savara, Vapore, Oriel Therapeutics and 11 more.

You May Also Like


Depotech is developing methods for drug delivery


PharmaJet develops, manufactures and markets vaccine and drug delivery products based on its proprietary needle free jet injection technology. PharmaJet's needle‐free injection technology delivers drugs and vaccines to intramuscular, subcutaneous and intradermal tissue depths. PharmaJet injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating risks of needle‐stick injuries and the cost burden of "sharps" waste management. Further benefits of PharmaJet injectors include the potential for dose‐sparing of vaccines, reducing the overall cost of vaccine delivery.


Medlogics is an early stage medical device company developing a broad platform technology for drug delivery. The initial focus is product development of polymer-free stent drug delivery.

Pantec Biosolutions Logo
Pantec Biosolutions

Pantec Biosolutions is a provider of transdermal drug delivery solutions.


Cytogel, Inc., is working on the development of promising drug candidates and drug delivery technologies


Replenish Inc is a Pasadena, Calif.-based developer of a drug delivery platform.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.